Schuessler Tissue Salts Kali Sulph Skin Balance 7

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
Schuessler Tissue Salts Kali Sulph Skin Balance 7
Generic name
KALI SULPHURICUM
Manufacturer
Martin & Pleasance Pty Ltd
Product type
HUMAN OTC DRUG
SPL set ID
0fa37814-6c70-4834-a0dc-5e729b80f3e5
SPL ID
395844ca-6baa-db3e-e063-6294a90a7726
Version
1
Effective date
2025-07-07
Source export date
2026-11-13
Source partition
4
Source file
https://download.open.fda.gov/drug/label/drug-label-0004-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-11-13/2aa9706206c534e56285cf80077b2cca2320f0a236e2aa30e80d064749f7c888/drug-label-0004-of-0014.json.zip
Source manifest SHA-256
8f2b6d063d44586cf97cedcdf1bdf9e261cc88632cc6855424b801bb206208d7
Import run
20261116T150851Z
Imported at
2026-11-16 15:58:10
Harmonized routes table
Harmonized routes
ORAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings Stop use and ask a doctor if • Symptoms persist for more than 7 days or worsen • Inflammation, fever or infection is present or develops • Fever gets worse or lasts more than 3 days If skin eruptions are severe, or painful, seek the advice of a doctor. If pregnant or breastfeeding , ask a health professional before use. Keep out of reach of children .

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.